From ARKK’s Bottom 10 Holdings Exposed for 2024ARK Innovation ETF, led by Cathie Wood, is experiencing a downward trend, trading lower by 5.3% this week and 8.7% year-on-year. The decline is not solely due to tech issues but is more influenced by the fund itself. The Nasdaq Composite and QQQ Trust also show higher returns. Info Tech is the third best-performing sector in 2024.
ARKK, an ETF with 37 names, has a portfolio allocation of 32.19%, with Coinbase Global (COIN) being the largest contributor at 9.86%. However, 27 of the 27 holdings have been a drag, with 21 down at least 10% or more. The top 10 worst performing names in ARKK during 2024 are listed below.
No. 10: Teladoc Health (TDOC) -32.5% YTD.
No. 9: Tesla (TSLA) -33.4% YTD.
No. 8: Roku (ROKU) -34.5% YTD.
No. 7: Prime Medicine (PRME) -34.6% YTD.
No. 6: 10x Genomics (TXG) -35.2% YTD.
No. 5: Ginkgo Bioworks (DNA) -35.8% YTD.
No. 4: Unity Software (U) -37.7% YTD.
No. 3: Verve Therapeutics (VERV) -38.1% YTD.
No. 2: Pacific Biosciences of California (PACB) -65.5% YTD.
No. 1: 2U, Inc. (TWOU) -70.9% YTD.
List of wealth crusher of Cathy Wood holdings
The top 10 worst-performing names within ARKK collectively constitute 27.75% of the exchange-traded funds portfolio.